Monthly revenue and year-on-year change for Lotus Pharm (1795) and WeLeader Biomedical (7713) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.
Year-on-year change
Monthly revenue history
| Month | Lotus Pharm | YoY | WeLeader Biomedical | YoY |
|---|---|---|---|---|
| Oct 2026 | NT$2.13 billion | -22.5% | NT$112.6 million | +15.3% |
| Sep 2026 | NT$2.77 billion | +128.0% | NT$116.6 million | +16.8% |
| Aug 2026 | NT$2.11 billion | +81.7% | NT$116.2 million | +14.8% |
| Jul 2026 | NT$2.49 billion | +3.9% | NT$120 million | +26.4% |
| Jun 2026 | NT$3.4 billion | +225.5% | NT$112.9 million | +15.2% |
| May 2026 | NT$2.32 billion | +105.8% | NT$111.3 million | +20.6% |
| Apr 2026 | NT$3.09 billion | +19.9% | NT$115 million | +38.8% |
| Mar 2026 | NT$4.35 billion | +173.6% | NT$102.3 million | +14.3% |
| Feb 2026 | NT$2.24 billion | +131.5% | NT$78.3 million | +4.6% |
| Jan 2026 | NT$2.05 billion | -5.5% | NT$98.3 million | +21.7% |
| Dec 2025 | NT$2.44 billion | +66.9% | NT$96.6 million | +21.0% |
| Nov 2025 | NT$1.06 billion | -0.2% | NT$100.9 million | +14.7% |
| Oct 2025 | NT$2.75 billion | +46.0% | NT$97.7 million | +22.0% |
← All Taiwan listed & OTC companies
Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16